Given that tumor‐infiltrating immune cells are significantly correlated with the prognosis of PRAD patients, we constructed an IPM for personalized prognostic prediction based on five tumor‐infiltrating immune cells, MDSCs, Th1 cells, T helper cells, Tgd, and pDC. This evidence concerns the gene ABCA1 and prostate adenocarcinoma.